Librium and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Librium (chlordiazepoxide hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Humira, and have Psoriasis.

The phase IV clinical study analyzes which people have Icterus when taking Librium. It is created by eHealthMe based on reports of 2,250 people who have side effects when taking Librium from the FDA, and is updated regularly.

What is Librium?

Librium has active ingredients of chlordiazepoxide hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 2,490 Librium users. Check the latest studies of Librium.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 2,092 drugs and 3,014 conditions by eHealthMe. Check the latest studies of Icterus.

On Apr, 09, 2026

2,250 people reported to have side effects when taking Librium.
Among them, 16 people (0.71%) have Icterus.

Among these 16 people:

How long have people been on Librium when they have Icterus? *

What is the gender of people who have Icterus when taking Librium? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Icterus when taking Librium? *

What are other drugs people take besides Librium? *

What are other side effects people have besides Icterus? *

Ascites (accumulation of fluid in the abdominal cavity): 6 people, 37.50%
Hepatic Steatosis (fatty liver disease): 4 people, 25.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 18.75%
Cholecystitis Acute (rapid infection of gallbladder): 3 people, 18.75%
Fall: 3 people, 18.75%
Hepatitis Alcoholic (inflammation of the liver due to alcohol): 3 people, 18.75%
Drug Dependence: 3 people, 18.75%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 18.75%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 18.75%
Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 18.75%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 9 people, 56.25%
Pernicious Anaemia (anaemia due to lack of vitamin b12): 2 people, 12.50%
Itching: 1 person, 6.25%
Iron Deficiency Anaemia: 1 person, 6.25%
Drug Dependence: 1 person, 6.25%
Depression: 1 person, 6.25%
Cardiomyopathy (weakening of the heart muscle): 1 person, 6.25%
Autoimmune Hepatitis: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Librium and have Icterus?

- Check whether Icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Librium:

Librium (2,490 reports)

Icterus treatments and more:

Icterus (33,621 reports)

How severe was Icterus and when was it recovered:

Icterus in Librium

Expand to all the drugs that have ingredients of chlordiazepoxide hydrochloride:

Icterus and drugs with ingredients of chlordiazepoxide hydrochloride (21 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Librium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (2,092 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (3,014 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlordiazepoxide hydrochloride (the active ingredients of Librium) and Librium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.